Trinity Biotech (TRIB) Net Cash Flow Growth (5y) (2014 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.17% |
| Dec 31, 2023 | -65.05% |
| Sep 30, 2023 | -36.40% |
| Dec 31, 2022 | -16.48% |
| Sep 30, 2022 | -22.49% |
| Jun 30, 2022 | -14.88% |
| Mar 31, 2022 | -88.92% |
| Dec 31, 2021 | -18.89% |
| Sep 30, 2021 | -39.54% |
| Jun 30, 2021 | -8.65% |
| Mar 31, 2021 | 25.74% |
| Dec 31, 2020 | 20.64% |
| Sep 30, 2020 | 14.24% |
| Jun 30, 2020 | 17.85% |
| Mar 31, 2020 | -11.53% |
| Dec 31, 2019 | -22.72% |
| Sep 30, 2019 | -2.73% |
| Jun 30, 2019 | -1.07% |
| Mar 31, 2019 | 27.97% |
| Dec 31, 2018 | -40.07% |
| Sep 30, 2018 | -3.65% |
| Jun 30, 2018 | -3.66% |
| Mar 31, 2018 | -26.09% |
| Dec 31, 2017 | -3.96% |
| Sep 30, 2017 | -4.02% |
| Jun 30, 2017 | -6.97% |
| Mar 31, 2017 | -55.27% |
| Dec 31, 2016 | 2.59% |
| Sep 30, 2016 | 3.43% |
| Jun 30, 2016 | -13.74% |
| Mar 31, 2016 | -20.09% |
| Dec 31, 2015 | -1.53% |
| Sep 30, 2015 | -5.65% |
| Jun 30, 2015 | -26.95% |
| Mar 31, 2015 | -17.38% |
| Dec 31, 2014 | 12.38% |
| Sep 30, 2014 | 6.08% |
| Jun 30, 2014 | -17.53% |
| Mar 31, 2014 | -19.51% |